The Phase 3 trial compared Roche’s divarasib with treatments sold by Amgen and Bristol Myers in patients with non-small cell ...

Celea Therapeutics, linked to PureTech Health, on Thursday completed a $180 million financing round for a late-stage trial ​of its lung disease drug, deupirfenidone, ‌in patients with idiopathic ...

The pouches, including cinnamon, coffee and spearmint flavors, may now be marketed using the risk modification claim that ...

After breakout creator box office hits, executives at VidCon say studios are embracing YouTubers while creator content ...

Artificial intelligence is rapidly transforming point-of-care ultrasound (POCUS) across trauma, emergency, and critical care ...

Mark Ritson argues that Supergirl’s soft launch and Backrooms’ breakout success point to a bigger marketing problem: legacy ...

It took a broke medical student, a $20 fish tank, and a radical idea that could one day turn failed organs into brand-new ...

The X Factor star Katie Waissel is back in hospital with a suspected blood clot on her lung, almost two days after being discharged while recovering from severe bacterial pneumonia ...

Those who give up smoking slow down their mental decline in old age as significantly as the brain otherwise ages in up to three years. A new study provides older smokers with a strong argument: it is ...

May was the busiest month of the year so far for U.S. FDA drug approvals, pushing the year-to-date total to 84 approvals and 20 new molecular entities through five months. Globally, drug approvals ...

Breathing is one of those things you never think about until it becomes difficult. Then it’s all you think about. If you’ve ...

Climate researchers warn that the Amazon is close to a tipping point. This threatens a transformation that poses a massive threat to the global climate, biodiversity and food supply.